Brief: Avalon Globocare And Adial Pharmaceuticals Announce Strategic Collaboration For Global Distribution Of Covid-19 Test Devices

Change Agents

22/10/2020 13:44

Oct 22 (Reuters) - Avalon Globocare Corp  AVCO.O :
    * AVALON GLOBOCARE AND ADIAL PHARMACEUTICALS ANNOUNCE
STRATEGIC
COLLABORATION FOR GLOBAL DISTRIBUTION OF COVID-19 POINT-OF-CARE
ANTIBODY RAPID TEST DEVICES
    * AVALON GLOBOCARE - ADIAL HAS GRANTED AVALON NON-EXCLUSIVE,
SUB-DISTRIBUTION RIGHTS WORLDWIDE FOR FASTEP COVID-19 IGG/IGM
RAPID TEST DEVICE
    * AVALON GLOBOCARE - ADIAL HAS GRANTED AVALON NON-EXCLUSIVE,
SUB-DISTRIBUTION RIGHTS WORLDWIDE FOR ASSURE/ECOSTEP COVID-19
IGG/IGM RAPID TEST DEVICE

Source text for Eikon:  ID:nGNX1Rhzvk 
Further company coverage:  AVCO.O 

 ((Reuters.Briefs@thomsonreuters.com;))